Cases 41 - 50 of 916
MAGO v. MYLAN LABORATORIES LTD. et al
as 1:2022cv07601
Plaintiff:
JHEINGEL MAGO
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MORGAN v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv00166
Plaintiff:
PHILLIP MORGAN
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND et al v. CELGENE CORPORATION et al
as 2:2022cv06694
Plaintiff:
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND and JACKSONVILLE POLICE OFFICERS AND FIRE FIGHTERS HEALTH INSURANCE TRUST
Defendant:
CELGENE CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, NATCO PHARMA LIMITED and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
PHILLIPS v. AJANTA PHARMA USA, INC. et al
as 2:2023cv00034
Plaintiff:
JR. DONALD PHILLIPS
Defendant:
AJANTA PHARMA USA, INC., ACTAVIS MID ATLANTIC LLC, AMNEAL PHARMACEUTICALS OF NEW YORK, LLC and others
Cause Of Action: 28 U.S.C. § 1446 Notice of Removal
COBERLY v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv07450
Plaintiff:
David Coberly
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01367
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BLAIR v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06632
Plaintiff:
CINDY LOU BLAIR
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD., AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In re: Mylan Inc. et al
as 1:2022mc00501
Petitioner:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Respondent:
Somaxon Pharmaceuticals Inc., Procom One Inc., Currax Pharmaceuticals LLC and others
1199SEIU NATIONAL BENEFIT FUND et al v. ACTAVIS HOLDCO US, INC. et al
as 2:2018cv02401
Defendant:
HERITAGE PHARMACEUTICALS, INC., PLIVA, INC., SANDOZ, INC. and others
Plaintiff:
1199SEIU NATIONAL BENEFIT FUND, SERGEANTS BENEVOLENT ASSOCIATON OF THE POLICE DEPARTMENT OF THE CITY OF NEW YORK HEALTH AND WELFARE FUND, SELF-INSURED SCHOOLS OF CALIFORNIA and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
